Upexi Issues 6.3 Million Shares and Warrants in $7.4 Million Direct Offering

Reuters
Feb 06
Upexi Issues 6.3 Million Shares and Warrants in $7.4 Million Direct Offering

Upexi Inc. has announced a definitive agreement with a single institutional investor for the sale and issuance of 6,337,000 shares of common stock and warrants to purchase up to 6,337,000 shares of common stock at a combined offering price of $1.17 per share and accompanying warrant. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire five years from the date of issuance, with a forced conversion at $5.00. Additionally, the company agreed to amend existing warrants issued in December 2025, reducing their exercise price from $4.00 to $2.83 per share and lowering the redemption price trigger from $8.50 to $7.00 per share. The offering is expected to close on or about February 9, 2026, subject to customary closing conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Upexi Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9650314) on February 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10